PROM1 and osteosarcoma: Following sterilization, cytotoxicity tests, and the separation of CSC from the human osteosarcoma cancer cell line (SAOS-2) with a cancer stem cell subpopulation harboring the CD133 surface marker, the functional polymeric magnetic nanoparticles that had been produced and described were employed.